Inventor
PFISTER JURG R
US37 patents
⚠️ This page may combine multiple inventors who share the name “PFISTER JURG R”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
SYNTEX INC
24 patentsUS5654304AAug 5, 1997
10,11-methanodibenzosuberane derivatives
SYNTEX INC33 citations94
US5643909AJul 1, 1997
10,11-Methanodibenzosuberane derivatives
SYNTEX INC37 citations94
US5436264AJul 25, 1995
N-aryloxyalkyl tryptamine α1 -adrenergic receptor antagonists
SYNTEX INC30 citations92
US4353922AOct 12, 1982
Anticholinergic bronchodilators
SYNTEX INC33 citations92
US4250097AFeb 10, 1981
Compositions for and a method of preventing diabetic complications
SYNTEX INC36 citations92
US4663320AMay 5, 1987
(2-oxo-1,2,3,5-tetrahydroimidazo[2,1-b]quinoazolinyl)oxyalkylamides, compositions and the use thereof
SYNTEX INC22 citations81
US4208423AJun 17, 1980
Anticholinergic bronchodilators
SYNTEX INC12 citations74
US3993669ANov 23, 1976
Mono- and disubstituted 1.4-benzopyrone-6-carboxylic acids and derivatives thereof
SYNTEX INC11 citations74
US5889007AMar 30, 1999
10, 11-methanodibenzosuberane derivatives
SYNTEX INC9 citations72
US4889866ADec 26, 1989
Arylsulfonyl dihydropyridine derivatives
SYNTEX INC15 citations72
US4228171AOct 14, 1980
Antichlorinergic bronchodilators
SYNTEX INC4 citations63
US4217361AAug 12, 1980
Disubstituted xanthone-2-carboxylic acid antiallergy agents
SYNTEX INC2 citations63
US3951618AApr 20, 1976
Method of use of, and compositions containing, disubstituted xanthone carboxylic acid compounds
SYNTEX INC2 citations63
US3949084AApr 6, 1976
Novel substituted xanthone carboxylic acid compounds
SYNTEX INC5 citations63
US4548949AOct 22, 1985
+2-[(3,4-Methylenedioxy)phenethyl]-5-[(3-carboxamido-4-hydroxy)-α-hydroxybenzyl]pyrrolidines
SYNTEX INC3 citations62
US5874434AFeb 23, 1999
10,11-methanodibenzosuberane derivatives
SYNTEX INC2 citations61
US4515727AMay 7, 1985
Allene containing arachidonic acid derivatives
SYNTEX INC3 citations54
US3989721ANov 2, 1976
Disubstituted xanthone carboxylic acid compounds
SYNTEX INC1 citations52
US3989720ANov 2, 1976
Disubstituted xanthone carboxylic acid compounds
SYNTEX INC0 citations52
US3988352AOct 26, 1976
Disubstituted xanthone carboxylic acid compounds
SYNTEX INC1 citations52
US3979414ASep 7, 1976
Disubstituted xanthone carboxylic acid compounds
SYNTEX INC0 citations52
US3965115AJun 22, 1976
Disubstituted xanthone carboxylic acid compounds
SYNTEX INC0 citations52
US3963753AJun 15, 1976
Disubstituted xanthone carboxylic acid compounds
SYNTEX INC1 citations52
US3963752AJun 15, 1976
Disubstituted xanthone carboxylic acid compounds
SYNTEX INC1 citations52
ARYX THERAPEUTICS
5 patentsUS6680387B2Jan 20, 2004
Materials and methods for the treatment of diabetes, hyperlipidemia, hypercholesterolemia, and atherosclerosis
ARYX THERAPEUTICS21 citations92
US7125886B2Oct 24, 2006
5-HT3 receptor antagonists and methods of use
ARYX THERAPEUTICS9 citations74
US6770655B2Aug 3, 2004
5-HT3 receptor antagonists and methods of use
ARYX THERAPEUTICS12 citations74
US7145020B2Dec 5, 2006
Materials and methods for treating coagulation disorders
ARYX THERAPEUTICS4 citations63
US6768008B2Jul 27, 2004
Materials and methods for the treatment of diabetes, hyperlipidemia, hypercholesterolemia, and atherosclerosis
ARYX THERAPEUTICS1 citations52
ARYX THERAPEUTICS INC
5 patentsUS6951877B2Oct 4, 2005
Materials and methods for treating hypercholesterolemia
ARYX THERAPEUTICS INC3 citations63
US7501436B2Mar 10, 2009
5-HT3 receptor antagonists and methods of use
ARYX THERAPEUTICS INC0 citations52
US7384973B2Jun 10, 2008
Materials and methods for treating hypercholesterolemia
ARYX THERAPEUTICS INC0 citations52
US7022722B2Apr 4, 2006
Materials and methods for the treatment of diabetes, hyperlipidemia, hypercholesterolemia, and atherosclerosis
ARYX THERAPEUTICS INC1 citations52
US6958355B2Oct 25, 2005
Materials and methods for the treatment of diabetes, hyperlipidemia, hypercholesterolemia, and atherosclerosis
ARYX THERAPEUTICS INC0 citations42